Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of MMH-407 in the Treatment of Acute Respiratory Viral Infection

NCT04244084 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT04244084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04244084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Placebo-controlled Parallel Group Randomized Clinical Trial of Efficacy and Safety of MMH-407 in the Treatment of Acute Respiratory Viral Infection
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
October 8, 2019
Completion date
April 9, 2020
Enrollment
240 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

viral respiratory infection